Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)

Incannex Healthcare (IXHL) posted quarterly Non Operating Income of $165000.0 for Q1 2026, down 84.06% year-on-year from $1.0 million in Q1 2025, and down 65.19% on a QoQ basis from $474000.0 in Q4 2025.

Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Non Operating Income for 5 consecutive years, with $165000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Non Operating Income fell 84.06% year-over-year to $165000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.0 million (down 637.02% YoY) and the FY2025 annual result came in at -$23.1 million, down 298.9% from the prior year.
  • Non Operating Income declined to $165000.0 in Q1 2026 per IXHL's latest filing, from $474000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for IXHL reached as high as $4.2 million in Q3 2023 and fell as low as -$24.1 million in Q2 2025.
  • A 5-year average of -$688857.1 and a median of $597500.0 in 2022 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2024 — Non Operating Income soared 16465.0% — and 2025, when it slumped 826.68%.
  • Year by year, Non Operating Income stood at $721000.0 in 2022, then soared by 280.31% to $2.7 million in 2023, then slumped by 132.46% to -$890000.0 in 2024, then surged by 153.26% to $474000.0 in 2025, then slumped by 65.19% to $165000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered $165000.0, $474000.0, and $387000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 165,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 165,000.00
Dec 31, 2025 474,000.00
Sep 30, 2025 387,000.00
Jun 30, 2025 -24.08 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 -890,000.00
Sep 30, 2024 834,000.00
Jun 30, 2024 3.31 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 2.74 Mn
Sep 30, 2023 4.17 Mn
Jun 30, 2023 20,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 721,000.00